Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 50,000,000
    Countries
    Sector(s)
    Italy : € 50,000,000
    Credit lines : € 50,000,000
    Signature date(s)
    24/07/2025 : € 50,000,000

    Summary sheet

    Release date
    31 July 2025
    Status
    Reference
    Signed | 24/07/2025
    20240932
    Project name
    Promoter - financial intermediary
    IFIS LOAN FOR SMES AND GENDER EQUALITY
    BANCA IFIS SPA
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 100 million
    not applicable
    Location
    Sector(s)
    Description
    Objectives

    The operation is a Multiple-Beneficiary Intermediated Loan (MBIL) supporting small and medium-sized enterprises (SMEs) in Italy's pharmacy sector.

    The aim is to enhance access to finance for the target beneficiaries. At least 30% of the EIB loan will support SMEs complying with the EIB's gender equality financing criteria, while at least 50% of the sub-projects are expected to be located in cohesion regions.

    Additionality and Impact

    The proposed operation, with a minimum 30% gender equality and a minimum 50% cohesion region windows, aims to address market failures related to access to finance for SMEs, including self-employed pharmacy professionals. Market failure arises due to information asymmetries between lender and borrower resulting in no or costly access to finance. This is particularly the case for new and/or women owned businesses.


    The operation also aims to generate positive externalities by promoting gender equality and women's economic empowerment, provision of health services and products offered by the pharmacies including in rural areas, as well as helping to reduce regional disparities.


    Banca IFIS/Credifarma brings in expertise and its widespread network of pharmacists benefitting the operation. The additional lending capacity with medium to long-term financing and lower financing costs provided through EIB's intervention will promote access to finance for final beneficiaries and generate positive effects on provision of healthcare products and services to citizens. In addition, Banca IFIS/Credifarma will be offered advisory support throughout the implementation to contribute to the intermediary's efforts to further measure, strengthen and expand its portfolio's contribution to gender equality goals going forward.


    Environmental aspects
    Procurement

    The operation falls within the scope of the EIB's Environmental and Social Standards - "Standard 11 Intermediated Finance". The Borrower / Financial Intermediary has adequate capacity, systems and processes in place for identifying, assessing, managing and monitoring environmental, climate and social (ECS) risks related to the potential sub-projects benefitting from EIB support. Final beneficiaries need to comply with the applicable national and EU environmental and social legislation.

    Final beneficiaries need to comply with the applicable national and EU legislation.

    Milestone
    Under appraisal
    Approved
    Signed
    9 July 2025
    24 July 2025

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications